We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Plavix's plot thickens

4 Mar 2004 By Robert Cyran

A study suggests that Sanofi’s biggest drug doesn’t work in combination with the world’s best selling pill. Concerns about Plavix’s patent have already rattled Aventis shareholders. This adds to the uncertainty.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)